Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imago Scientific Instruments was a pioneer in the field of Atom Probe Tomography (APT), developing high-resolution microscopy tools for three-dimensional atomic-scale analysis. The company's flagship product line, the Local Electrode Atom Probe (LEAP), revolutionized the ability to visualize and identify individual atoms within a variety of materials. While its primary market was the semiconductor and materials science sectors, the technology has significant applications in life sciences, including the study of biomineralized tissues and the characterization of medical implants. In 2010, Imago was acquired by AMETEK and integrated into its CAMECA business unit, where the LEAP technology continues to be developed. The company's contributions remain foundational to the field of nanotechnology and advanced materials characterization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imago Scientific Instruments.